Phenotypes associated with this allele
mortality/aging
|
• mice have a less than 40% survival rate at 1 year
|
immune system
|
• IgG deposition in kidney glomeruli is seen at 20 weeks of age
|
|
• mice show autoantibodies that are specifically seen in lupus; ssDNA, dsDNA, dsRNA and chromatin
|
|
• anti-nuclear antibodies in the sera in 20-week old mice
|
|
• mice exhibit chromatin autoantibodies at 8 weeks of age and at 20 weeks of age, mice show chromatin antibodies at amounts comparable to those seen in NZB/NZW mice
|
hematopoietic system
|
• IgG deposition in kidney glomeruli is seen at 20 weeks of age
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd79atm1(cre)Reth mutation
(3 available);
any
Cd79a mutation
(22 available)
Inpp5dtm1Rav mutation
(1 available);
any
Inpp5d mutation
(93 available)
Tg(IghAb36-65)1Wys mutation
(0 available)
|
|
|
immune system
|
• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection
|
|
• increase in frequency of plasma cells in the B cell population (4.96% of B cells compared to 0.04% in controls)
|
|
• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection
|
|
• cell surface mIgM and mIgD are reduced 50% in B cells and B cells express reduced CD93, CD95, and CD80 indicating a loss of anergic B cells
• B cells lose features of anergy, including antigen unresponsiveness measured by BCR aggregation-induced Akt activation and calcium mobilization
• increase in frequency of B cells with activated phenotype (CD86+)
|
|
• mice spontaneously express about 4-fold increased autoantibody by 20 weeks of age
|
hematopoietic system
|
• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection
|
|
• increase in frequency of plasma cells in the B cell population (4.96% of B cells compared to 0.04% in controls)
|
|
• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection
|
behavior/neurological
|
• mutants exhibit lethargy by 4 months of age
|
|
• mutants exhibit a hunched posture by 4 months of age
|
growth/size/body
|
• mutants exhibit weight loss by 4 months of age
|
|
• mutants exhibit splenomegaly by 4 months of age
|
hematopoietic system
|
• mutants exhibit splenomegaly by 4 months of age
|
|
• CD19+ B cells are larger than B cells from wild-type mice
• B cell neoplasia
|
|
• reduction in the frequency of B cells in asymptomatic double mutant mice as compared to controls or either single mutant mouse
|
|
• mutants older than 6 months of age have a 3-fold increase in the percentage of recirculating B cells in the blood, concurrent with onset of disease
|
|
• tissues containing the expanded B cell population also display an expansion of CD11b+ myeloid cells
|
|
• spleens of mutants over 6 months of age exhibit an expansion of CD19+ B cells, resulting in enlarged white pulp areas that often infiltrate and compress the red pulp
|
|
• B cells exhibit enhanced survival
|
|
• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not
• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice
|
immune system
|
• mutants exhibit splenomegaly by 4 months of age
|
|
• B cell neoplasia
• CD19+ B cells are larger than B cells from wild-type mice
|
|
• reduction in the frequency of B cells in asymptomatic double mutant mice as compared to controls or either single mutant mouse
|
|
• mutants older than 6 months of age have a 3-fold increase in the percentage of recirculating B cells in the blood, concurrent with onset of disease
|
|
• tissues containing the expanded B cell population also display an expansion of CD11b+ myeloid cells
|
|
• spleens of mutants over 6 months of age exhibit an expansion of CD19+ B cells, resulting in enlarged white pulp areas that often infiltrate and compress the red pulp
|
|
• B cells exhibit enhanced survival
|
|
• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not
• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice
|
integument
|
• mutants exhibit ruffled fur by 4 months of age
|
mortality/aging
|
• severe morbidity and death occurs in all mutants by 1 year of age
|
neoplasm
|
• mutants develop marginal zone lymphoma, and less frequently, follicular B cell lymphoma or centroblastic lymphoma
|
|
• mutants develop spontaneous and lethal mature B cell neoplasms consistent with marginal zone lymphoma
|
|
• lymphoma infiltrates are seen in nonlymphoid tissues, including liver, lung, heart, and kidney
|
cellular
|
• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not
• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice
|
hematopoietic system
|
• splenomegaly develops at about 5 weeks of age
|
|
• marginal zone B cells are depleted
|
|
• marginal zone macrophages are reorganized
|
immune system
|
• splenomegaly develops at about 5 weeks of age
|
|
• marginal zone B cells are depleted
|
|
• marginal zone macrophages are reorganized
|
growth/size/body
|
• splenomegaly develops at about 5 weeks of age
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Inpp5dtm1Rav mutation
(1 available);
any
Inpp5d mutation
(93 available)
Tg(Cd4-cre)1Cwi mutation
(10 available)
|
|
|
immune system
|
• APC/OVA primed peripheral CD8+ cells have significantly enhanced cytolitic efficiency
|
|
• under nonpolarizing conditions, IFNgamma levels are higher
|
|
• following infection with Alu/NP-CGG, B cell germinal centers are reduced 3-fold
|
|
• following infection with Alu/NP-CGG, Th2 cytokine levels are reduced
|
|
• following infection with Alu/NP-CGG, lower levels of IL-4, IL-5, and IL-13 are produced
• under nonpolarizing conditions, markedly lower levels of IL-4, IL-5, and IL-13 are produced
|
|
• following infection with S. mansoni, mice have smaller granulomas and somewhat reduced levels of eosinophils in the lung and significantly reduced levels of IL-13 Ralpha2 in serum
• in vitro exposure of lymph nodes with ConA or Schistosome egg antigen results in a reduced production of IL4 and IL5 and reduced proliferation of T cells
|
homeostasis/metabolism
hematopoietic system
|
• APC/OVA primed peripheral CD8+ cells have significantly enhanced cytolitic efficiency
|